Company News for April 03, 2017

• Shares of FMC Corporation (FMC) advanced 13.2% after the company agreed to buy E I Du Pont De Nemours And Co's (DD) crop protection business. 

 

• BlackBerry Ltd’s (BBRY) shares advanced 11.5% after reporting a fiscal 2017 fourth quarter loss of $0.01 per share, which beat the Zacks Consensus Estimate of a loss of $0.04 per share 

 

• Shares of Akari Therapeutics, Plc (AKTX) gained 58.1% after the FDA granted Fast Track designation for its treatment of paroxysmal nocturnal hemoglobinuria (PNH)

 

• TRC Companies, Inc.’s (TRR) shares gained 46% after private equity firm New Mountain Capital decided to acquire the company

• Shares of FMC Corporation (FMC) advanced 13.2% after the company agreed to buy E I Du Pont De Nemours And Co's (DD) crop protection business. 

 

• BlackBerry Ltd’s (BBRY) shares advanced 11.5% after reporting a fiscal 2017 fourth quarter loss of $0.01 per share, which beat the Zacks Consensus Estimate of a loss of $0.04 per share 

 

• Shares of Akari Therapeutics, Plc (AKTX) gained 58.1% after the FDA granted Fast Track designation for its treatment of paroxysmal nocturnal hemoglobinuria (PNH)

 

• TRC Companies, Inc.’s (TRR) shares gained 46% after private equity firm New Mountain Capital decided to acquire the company

• Shares of FMC Corporation (FMC) advanced 13.2% after the company agreed to buy E I Du Pont De Nemours And Co's (DD) crop protection business. 

 

• BlackBerry Ltd’s (BBRY) shares advanced 11.5% after reporting a fiscal 2017 fourth quarter loss of $0.01 per share, which beat the Zacks Consensus Estimate of a loss of $0.04 per share 

 

• Shares of Akari Therapeutics, Plc (AKTX) gained 58.1% after the FDA granted Fast Track designation for its treatment of paroxysmal nocturnal hemoglobinuria (PNH)

 

• TRC Companies, Inc.’s (TRR) shares gained 46% after private equity firm New Mountain Capital decided to acquire the company

• Shares of FMC Corporation (FMC) advanced 13.2% after the company agreed to buy E I Du Pont De Nemours And Co's (DD) crop protection business. 

 

• BlackBerry Ltd’s (BBRY) shares advanced 11.5% after reporting a fiscal 2017 fourth quarter loss of $0.01 per share, which beat the Zacks Consensus Estimate of a loss of $0.04 per share 

 

• Shares of Akari Therapeutics, Plc (AKTX) gained 58.1% after the FDA granted Fast Track designation for its treatment of paroxysmal nocturnal hemoglobinuria (PNH)

 

• TRC Companies, Inc.’s (TRR) shares gained 46% after private equity firm New Mountain Capital decided to acquire the company

  • Shares of FMC Corporation FMC advanced 13.2% after the company agreed to buy E I Du Pont De Nemours And Co's DD crop protection business.

  • BlackBerry Ltd’s BBRY shares advanced 11.5% after reporting a fiscal 2017 fourth quarter loss of $0.01 per share, which beat the Zacks Consensus Estimate of a loss of $0.04 per share 

  • Shares of Akari Therapeutics, Plc AKTX gained 58.1% after the FDA granted Fast Track designation for its treatment of paroxysmal nocturnal hemoglobinuria (PNH)

  • TRC Companies, Inc.’s TRR shares gained 46% after private equity firm New Mountain Capital decided to acquire the company

• Shares of FMC Corporation (FMC) advanced 13.2% after the company agreed to buy E I Du Pont De Nemours And Co's (DD) crop protection business. 

 

• BlackBerry Ltd’s (BBRY) shares advanced 11.5% after reporting a fiscal 2017 fourth quarter loss of $0.01 per share, which beat the Zacks Consensus Estimate of a loss of $0.04 per share 

 

• Shares of Akari Therapeutics, Plc (AKTX) gained 58.1% after the FDA granted Fast Track designation for its treatment of paroxysmal nocturnal hemoglobinuria (PNH)

 

• TRC Companies, Inc.’s (TRR) shares gained 46% after private equity firm New Mountain Capital decided to acquire the compan


Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report
 
E.I. du Pont de Nemours and Company (DD): Free Stock Analysis Report
 
FMC Corporation (FMC): Free Stock Analysis Report
 
BlackBerry Limited (BBRY): Free Stock Analysis Report
 
Akari Therapeutics PLC (AKTX): Free Stock Analysis Report
 
To read this article on Zacks.com click here.
 
Zacks Investment Research

Advertisement